 | • レポートコード：QY2203B01431 • 出版社/出版日：QYResearch / 2022年3月11日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のアミノグリコシド薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアミノグリコシド薬の世界市場のxxx％を占める「ネオマイシン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のアミノグリコシド薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのアミノグリコシド薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのアミノグリコシド薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 アミノグリコシド薬のグローバル主要メーカーには、Jemicare、Teva、Novartis Pharmaceuticals、Fangyuan-pharma、Aike Pharmaceutical、Cipla、Pfizer、FRESENIUS KABI、Sun Pharma、Hikma、Lannett Companyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アミノグリコシド薬市場は、種類と用途によって区分されます。世界のアミノグリコシド薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチミシン、その他 【用途別セグメント】 病院、小売薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アミノグリコシド薬製品概要 - 種類別市場（ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチミシン、その他） - 用途別市場（病院、小売薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のアミノグリコシド薬販売量予測2017-2028 - 世界のアミノグリコシド薬売上予測2017-2028 - アミノグリコシド薬の地域別販売量 - アミノグリコシド薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アミノグリコシド薬販売量 - 主要メーカー別アミノグリコシド薬売上 - 主要メーカー別アミノグリコシド薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチミシン、その他） - アミノグリコシド薬の種類別販売量 - アミノグリコシド薬の種類別売上 - アミノグリコシド薬の種類別価格 ・用途別市場規模（病院、小売薬局、その他） - アミノグリコシド薬の用途別販売量 - アミノグリコシド薬の用途別売上 - アミノグリコシド薬の用途別価格 ・北米市場 - 北米のアミノグリコシド薬市場規模（種類別、用途別） - 主要国別のアミノグリコシド薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアミノグリコシド薬市場規模（種類別、用途別） - 主要国別のアミノグリコシド薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアミノグリコシド薬市場規模（種類別、用途別） - 主要国別のアミノグリコシド薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアミノグリコシド薬市場規模（種類別、用途別） - 主要国別のアミノグリコシド薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアミノグリコシド薬市場規模（種類別、用途別） - 主要国別のアミノグリコシド薬市場規模（トルコ、サウジアラビア） ・企業情報 Jemicare、Teva、Novartis Pharmaceuticals、Fangyuan-pharma、Aike Pharmaceutical、Cipla、Pfizer、FRESENIUS KABI、Sun Pharma、Hikma、Lannett Company ・産業チェーン及び販売チャネル分析 - アミノグリコシド薬の産業チェーン分析 - アミノグリコシド薬の原材料 - アミノグリコシド薬の生産プロセス - アミノグリコシド薬の販売及びマーケティング - アミノグリコシド薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アミノグリコシド薬の産業動向 - アミノグリコシド薬のマーケットドライバー - アミノグリコシド薬の課題 - アミノグリコシド薬の阻害要因 ・主な調査結果 |
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
Market Analysis and Insights: Global Aminoglycoside Drug Market
Due to the COVID-19 pandemic, the global Aminoglycoside Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Neomycin accounting for % of the Aminoglycoside Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Aminoglycoside Drug market size is valued at US$ million in 2021, while the US and Europe Aminoglycoside Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Aminoglycoside Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Aminoglycoside Drug include Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, FRESENIUS KABI and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Aminoglycoside Drug Scope and Segment
Aminoglycoside Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Aminoglycoside Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Segment by Application
Hospital
Retail Pharmacy
Other
By Company
Jemicare
Teva
Novartis Pharmaceuticals
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
FRESENIUS KABI
Sun Pharma
Hikma
Lannett Company
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Aminoglycoside Drug Product Introduction
1.2 Market by Type
1.2.1 Global Aminoglycoside Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Etimicin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Aminoglycoside Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Aminoglycoside Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Aminoglycoside Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Aminoglycoside Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Aminoglycoside Drug Sales by Region
2.4.1 Global Aminoglycoside Drug Sales by Region (2017-2022)
2.4.2 Global Sales Aminoglycoside Drug by Region (2023-2028)
2.5 Global Aminoglycoside Drug Revenue by Region
2.5.1 Global Aminoglycoside Drug Revenue by Region (2017-2022)
2.5.2 Global Aminoglycoside Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Aminoglycoside Drug Sales by Manufacturers
3.1.1 Global Top Aminoglycoside Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Aminoglycoside Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aminoglycoside Drug in 2021
3.2 Global Aminoglycoside Drug Revenue by Manufacturers
3.2.1 Global Aminoglycoside Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Aminoglycoside Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Aminoglycoside Drug Revenue in 2021
3.3 Global Aminoglycoside Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Aminoglycoside Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Aminoglycoside Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Aminoglycoside Drug Sales by Type
4.1.1 Global Aminoglycoside Drug Historical Sales by Type (2017-2022)
4.1.2 Global Aminoglycoside Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Aminoglycoside Drug Sales Market Share by Type (2017-2028)
4.2 Global Aminoglycoside Drug Revenue by Type
4.2.1 Global Aminoglycoside Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Aminoglycoside Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Aminoglycoside Drug Revenue Market Share by Type (2017-2028)
4.3 Global Aminoglycoside Drug Price by Type
4.3.1 Global Aminoglycoside Drug Price by Type (2017-2022)
4.3.2 Global Aminoglycoside Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Aminoglycoside Drug Sales by Application
5.1.1 Global Aminoglycoside Drug Historical Sales by Application (2017-2022)
5.1.2 Global Aminoglycoside Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Aminoglycoside Drug Sales Market Share by Application (2017-2028)
5.2 Global Aminoglycoside Drug Revenue by Application
5.2.1 Global Aminoglycoside Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Aminoglycoside Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Aminoglycoside Drug Revenue Market Share by Application (2017-2028)
5.3 Global Aminoglycoside Drug Price by Application
5.3.1 Global Aminoglycoside Drug Price by Application (2017-2022)
5.3.2 Global Aminoglycoside Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Aminoglycoside Drug Market Size by Type
6.1.1 North America Aminoglycoside Drug Sales by Type (2017-2028)
6.1.2 North America Aminoglycoside Drug Revenue by Type (2017-2028)
6.2 North America Aminoglycoside Drug Market Size by Application
6.2.1 North America Aminoglycoside Drug Sales by Application (2017-2028)
6.2.2 North America Aminoglycoside Drug Revenue by Application (2017-2028)
6.3 North America Aminoglycoside Drug Market Size by Country
6.3.1 North America Aminoglycoside Drug Sales by Country (2017-2028)
6.3.2 North America Aminoglycoside Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Aminoglycoside Drug Market Size by Type
7.1.1 Europe Aminoglycoside Drug Sales by Type (2017-2028)
7.1.2 Europe Aminoglycoside Drug Revenue by Type (2017-2028)
7.2 Europe Aminoglycoside Drug Market Size by Application
7.2.1 Europe Aminoglycoside Drug Sales by Application (2017-2028)
7.2.2 Europe Aminoglycoside Drug Revenue by Application (2017-2028)
7.3 Europe Aminoglycoside Drug Market Size by Country
7.3.1 Europe Aminoglycoside Drug Sales by Country (2017-2028)
7.3.2 Europe Aminoglycoside Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Aminoglycoside Drug Market Size by Type
8.1.1 Asia Pacific Aminoglycoside Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Aminoglycoside Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Aminoglycoside Drug Market Size by Application
8.2.1 Asia Pacific Aminoglycoside Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Aminoglycoside Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Aminoglycoside Drug Market Size by Region
8.3.1 Asia Pacific Aminoglycoside Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Aminoglycoside Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Aminoglycoside Drug Market Size by Type
9.1.1 Latin America Aminoglycoside Drug Sales by Type (2017-2028)
9.1.2 Latin America Aminoglycoside Drug Revenue by Type (2017-2028)
9.2 Latin America Aminoglycoside Drug Market Size by Application
9.2.1 Latin America Aminoglycoside Drug Sales by Application (2017-2028)
9.2.2 Latin America Aminoglycoside Drug Revenue by Application (2017-2028)
9.3 Latin America Aminoglycoside Drug Market Size by Country
9.3.1 Latin America Aminoglycoside Drug Sales by Country (2017-2028)
9.3.2 Latin America Aminoglycoside Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Aminoglycoside Drug Market Size by Type
10.1.1 Middle East and Africa Aminoglycoside Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Aminoglycoside Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Aminoglycoside Drug Market Size by Application
10.2.1 Middle East and Africa Aminoglycoside Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Aminoglycoside Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Aminoglycoside Drug Market Size by Country
10.3.1 Middle East and Africa Aminoglycoside Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Aminoglycoside Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Jemicare
11.1.1 Jemicare Corporation Information
11.1.2 Jemicare Overview
11.1.3 Jemicare Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Jemicare Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Jemicare Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Novartis Pharmaceuticals
11.3.1 Novartis Pharmaceuticals Corporation Information
11.3.2 Novartis Pharmaceuticals Overview
11.3.3 Novartis Pharmaceuticals Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Pharmaceuticals Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Pharmaceuticals Recent Developments
11.4 Fangyuan-pharma
11.4.1 Fangyuan-pharma Corporation Information
11.4.2 Fangyuan-pharma Overview
11.4.3 Fangyuan-pharma Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Fangyuan-pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fangyuan-pharma Recent Developments
11.5 Aike Pharmaceutical
11.5.1 Aike Pharmaceutical Corporation Information
11.5.2 Aike Pharmaceutical Overview
11.5.3 Aike Pharmaceutical Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Aike Pharmaceutical Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aike Pharmaceutical Recent Developments
11.6 Cipla
11.6.1 Cipla Corporation Information
11.6.2 Cipla Overview
11.6.3 Cipla Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cipla Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 FRESENIUS KABI
11.8.1 FRESENIUS KABI Corporation Information
11.8.2 FRESENIUS KABI Overview
11.8.3 FRESENIUS KABI Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 FRESENIUS KABI Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 FRESENIUS KABI Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Corporation Information
11.9.2 Sun Pharma Overview
11.9.3 Sun Pharma Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sun Pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharma Recent Developments
11.10 Hikma
11.10.1 Hikma Corporation Information
11.10.2 Hikma Overview
11.10.3 Hikma Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hikma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hikma Recent Developments
11.11 Lannett Company
11.11.1 Lannett Company Corporation Information
11.11.2 Lannett Company Overview
11.11.3 Lannett Company Aminoglycoside Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lannett Company Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lannett Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Aminoglycoside Drug Industry Chain Analysis
12.2 Aminoglycoside Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aminoglycoside Drug Production Mode & Process
12.4 Aminoglycoside Drug Sales and Marketing
12.4.1 Aminoglycoside Drug Sales Channels
12.4.2 Aminoglycoside Drug Distributors
12.5 Aminoglycoside Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Aminoglycoside Drug Industry Trends
13.2 Aminoglycoside Drug Market Drivers
13.3 Aminoglycoside Drug Market Challenges
13.4 Aminoglycoside Drug Market Restraints
14 Key Findings in The Global Aminoglycoside Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Aminoglycoside Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Neomycin
Table 3. Major Manufacturers of Tobramycin
Table 4. Major Manufacturers of Gentamicin
Table 5. Major Manufacturers of Amikacin
Table 6. Major Manufacturers of Etimicin
Table 7. Major Manufacturers of Others
Table 8. Global Aminoglycoside Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Aminoglycoside Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Aminoglycoside Drug Sales by Region (2017-2022) & (Units)
Table 11. Global Aminoglycoside Drug Sales Market Share by Region (2017-2022)
Table 12. Global Aminoglycoside Drug Sales by Region (2023-2028) & (Units)
Table 13. Global Aminoglycoside Drug Sales Market Share by Region (2023-2028)
Table 14. Global Aminoglycoside Drug Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Aminoglycoside Drug Revenue Market Share by Region (2017-2022)
Table 16. Global Aminoglycoside Drug Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Aminoglycoside Drug Revenue Market Share by Region (2023-2028)
Table 18. Global Aminoglycoside Drug Sales by Manufacturers (2017-2022) & (Units)
Table 19. Global Aminoglycoside Drug Sales Share by Manufacturers (2017-2022)
Table 20. Global Aminoglycoside Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Aminoglycoside Drug Revenue Share by Manufacturers (2017-2022)
Table 22. Aminoglycoside Drug Price by Manufacturers (2017-2022) &(US$/Unit)
Table 23. Global Aminoglycoside Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Aminoglycoside Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycoside Drug as of 2021)
Table 25. Aminoglycoside Drug Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Aminoglycoside Drug Product Offered
Table 27. Date of Manufacturers Enter into Aminoglycoside Drug Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 30. Global Aminoglycoside Drug Sales by Type (2023-2028) & (Units)
Table 31. Global Aminoglycoside Drug Sales Share by Type (2017-2022)
Table 32. Global Aminoglycoside Drug Sales Share by Type (2023-2028)
Table 33. Global Aminoglycoside Drug Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Aminoglycoside Drug Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Aminoglycoside Drug Revenue Share by Type (2017-2022)
Table 36. Global Aminoglycoside Drug Revenue Share by Type (2023-2028)
Table 37. Aminoglycoside Drug Price by Type (2017-2022) & (US$/Unit)
Table 38. Global Aminoglycoside Drug Price Forecast by Type (2023-2028) & (US$/Unit)
Table 39. Global Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 40. Global Aminoglycoside Drug Sales by Application (2023-2028) & (Units)
Table 41. Global Aminoglycoside Drug Sales Share by Application (2017-2022)
Table 42. Global Aminoglycoside Drug Sales Share by Application (2023-2028)
Table 43. Global Aminoglycoside Drug Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Aminoglycoside Drug Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Aminoglycoside Drug Revenue Share by Application (2017-2022)
Table 46. Global Aminoglycoside Drug Revenue Share by Application (2023-2028)
Table 47. Aminoglycoside Drug Price by Application (2017-2022) & (US$/Unit)
Table 48. Global Aminoglycoside Drug Price Forecast by Application (2023-2028) & (US$/Unit)
Table 49. North America Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 50. North America Aminoglycoside Drug Sales by Type (2023-2028) & (Units)
Table 51. North America Aminoglycoside Drug Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Aminoglycoside Drug Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 54. North America Aminoglycoside Drug Sales by Application (2023-2028) & (Units)
Table 55. North America Aminoglycoside Drug Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Aminoglycoside Drug Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Aminoglycoside Drug Sales by Country (2017-2022) & (Units)
Table 58. North America Aminoglycoside Drug Sales by Country (2023-2028) & (Units)
Table 59. North America Aminoglycoside Drug Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Aminoglycoside Drug Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 62. Europe Aminoglycoside Drug Sales by Type (2023-2028) & (Units)
Table 63. Europe Aminoglycoside Drug Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Aminoglycoside Drug Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 66. Europe Aminoglycoside Drug Sales by Application (2023-2028) & (Units)
Table 67. Europe Aminoglycoside Drug Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Aminoglycoside Drug Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Aminoglycoside Drug Sales by Country (2017-2022) & (Units)
Table 70. Europe Aminoglycoside Drug Sales by Country (2023-2028) & (Units)
Table 71. Europe Aminoglycoside Drug Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Aminoglycoside Drug Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 74. Asia Pacific Aminoglycoside Drug Sales by Type (2023-2028) & (Units)
Table 75. Asia Pacific Aminoglycoside Drug Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Aminoglycoside Drug Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 78. Asia Pacific Aminoglycoside Drug Sales by Application (2023-2028) & (Units)
Table 79. Asia Pacific Aminoglycoside Drug Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Aminoglycoside Drug Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Aminoglycoside Drug Sales by Region (2017-2022) & (Units)
Table 82. Asia Pacific Aminoglycoside Drug Sales by Region (2023-2028) & (Units)
Table 83. Asia Pacific Aminoglycoside Drug Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Aminoglycoside Drug Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 86. Latin America Aminoglycoside Drug Sales by Type (2023-2028) & (Units)
Table 87. Latin America Aminoglycoside Drug Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Aminoglycoside Drug Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 90. Latin America Aminoglycoside Drug Sales by Application (2023-2028) & (Units)
Table 91. Latin America Aminoglycoside Drug Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Aminoglycoside Drug Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Aminoglycoside Drug Sales by Country (2017-2022) & (Units)
Table 94. Latin America Aminoglycoside Drug Sales by Country (2023-2028) & (Units)
Table 95. Latin America Aminoglycoside Drug Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Aminoglycoside Drug Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Aminoglycoside Drug Sales by Type (2017-2022) & (Units)
Table 98. Middle East and Africa Aminoglycoside Drug Sales by Type (2023-2028) & (Units)
Table 99. Middle East and Africa Aminoglycoside Drug Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Aminoglycoside Drug Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Aminoglycoside Drug Sales by Application (2017-2022) & (Units)
Table 102. Middle East and Africa Aminoglycoside Drug Sales by Application (2023-2028) & (Units)
Table 103. Middle East and Africa Aminoglycoside Drug Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Aminoglycoside Drug Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Aminoglycoside Drug Sales by Country (2017-2022) & (Units)
Table 106. Middle East and Africa Aminoglycoside Drug Sales by Country (2023-2028) & (Units)
Table 107. Middle East and Africa Aminoglycoside Drug Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Aminoglycoside Drug Revenue by Country (2023-2028) & (US$ Million)
Table 109. Jemicare Corporation Information
Table 110. Jemicare Description and Major Businesses
Table 111. Jemicare Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Jemicare Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Jemicare Recent Developments
Table 114. Teva Corporation Information
Table 115. Teva Description and Major Businesses
Table 116. Teva Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Teva Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Teva Recent Developments
Table 119. Novartis Pharmaceuticals Corporation Information
Table 120. Novartis Pharmaceuticals Description and Major Businesses
Table 121. Novartis Pharmaceuticals Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Novartis Pharmaceuticals Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis Pharmaceuticals Recent Developments
Table 124. Fangyuan-pharma Corporation Information
Table 125. Fangyuan-pharma Description and Major Businesses
Table 126. Fangyuan-pharma Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Fangyuan-pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Fangyuan-pharma Recent Developments
Table 129. Aike Pharmaceutical Corporation Information
Table 130. Aike Pharmaceutical Description and Major Businesses
Table 131. Aike Pharmaceutical Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Aike Pharmaceutical Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Aike Pharmaceutical Recent Developments
Table 134. Cipla Corporation Information
Table 135. Cipla Description and Major Businesses
Table 136. Cipla Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Cipla Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Cipla Recent Developments
Table 139. Pfizer Corporation Information
Table 140. Pfizer Description and Major Businesses
Table 141. Pfizer Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Pfizer Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Pfizer Recent Developments
Table 144. FRESENIUS KABI Corporation Information
Table 145. FRESENIUS KABI Description and Major Businesses
Table 146. FRESENIUS KABI Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. FRESENIUS KABI Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. FRESENIUS KABI Recent Developments
Table 149. Sun Pharma Corporation Information
Table 150. Sun Pharma Description and Major Businesses
Table 151. Sun Pharma Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Sun Pharma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Sun Pharma Recent Developments
Table 154. Hikma Corporation Information
Table 155. Hikma Description and Major Businesses
Table 156. Hikma Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Hikma Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Hikma Recent Developments
Table 159. Lannett Company Corporation Information
Table 160. Lannett Company Description and Major Businesses
Table 161. Lannett Company Aminoglycoside Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Lannett Company Aminoglycoside Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Lannett Company Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Aminoglycoside Drug Distributors List
Table 167. Aminoglycoside Drug Customers List
Table 168. Aminoglycoside Drug Market Trends
Table 169. Aminoglycoside Drug Market Drivers
Table 170. Aminoglycoside Drug Market Challenges
Table 171. Aminoglycoside Drug Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Aminoglycoside Drug Product Picture
Figure 3. Global Aminoglycoside Drug Market Share by Type in 2021 & 2028
Figure 3. Neomycin Product Picture
Figure 4. Tobramycin Product Picture
Figure 5. Gentamicin Product Picture
Figure 6. Amikacin Product Picture
Figure 7. Etimicin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Aminoglycoside Drug Market Share by Application in 2021 & 2028
Figure 10. Hospital
Figure 11. Retail Pharmacy
Figure 12. Other
Figure 13. Aminoglycoside Drug Report Years Considered
Figure 14. Global Aminoglycoside Drug Sales 2017-2028 (Units)
Figure 15. Global Aminoglycoside Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Aminoglycoside Drug Revenue 2017-2028 (US$ Million)
Figure 17. Global Aminoglycoside Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Aminoglycoside Drug Sales Market Share by Region (2017-2022)
Figure 19. Global Aminoglycoside Drug Sales Market Share by Region (2023-2028)
Figure 20. North America Aminoglycoside Drug Sales YoY (2017-2028) & (Units)
Figure 21. North America Aminoglycoside Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Aminoglycoside Drug Sales YoY (2017-2028) & (Units)
Figure 23. Europe Aminoglycoside Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Aminoglycoside Drug Sales YoY (2017-2028) & (Units)
Figure 25. Asia-Pacific Aminoglycoside Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Aminoglycoside Drug Sales YoY (2017-2028) & (Units)
Figure 27. Latin America Aminoglycoside Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Aminoglycoside Drug Sales YoY (2017-2028) & (Units)
Figure 29. Middle East & Africa Aminoglycoside Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Aminoglycoside Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Aminoglycoside Drug in the World: Market Share by Aminoglycoside Drug Revenue in 2021
Figure 32. Global Aminoglycoside Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Aminoglycoside Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Aminoglycoside Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Aminoglycoside Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Aminoglycoside Drug Revenue Market Share by Application (2017-2028)
Figure 37. North America Aminoglycoside Drug Sales Market Share by Type (2017-2028)
Figure 38. North America Aminoglycoside Drug Revenue Market Share by Type (2017-2028)
Figure 39. North America Aminoglycoside Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Aminoglycoside Drug Revenue Market Share by Application (2017-2028)
Figure 41. North America Aminoglycoside Drug Sales Share by Country (2017-2028)
Figure 42. North America Aminoglycoside Drug Revenue Share by Country (2017-2028)
Figure 43. United States Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Aminoglycoside Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Aminoglycoside Drug Revenue Market Share by Type (2017-2028)
Figure 47. Europe Aminoglycoside Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe Aminoglycoside Drug Revenue Market Share by Application (2017-2028)
Figure 49. Europe Aminoglycoside Drug Sales Share by Country (2017-2028)
Figure 50. Europe Aminoglycoside Drug Revenue Share by Country (2017-2028)
Figure 51. Germany Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 52. France Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Aminoglycoside Drug Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Aminoglycoside Drug Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Aminoglycoside Drug Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Aminoglycoside Drug Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Aminoglycoside Drug Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Aminoglycoside Drug Revenue Share by Region (2017-2028)
Figure 62. China Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 65. India Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Aminoglycoside Drug Sales Market Share by Type (2017-2028)
Figure 72. Latin America Aminoglycoside Drug Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Aminoglycoside Drug Sales Market Share by Application (2017-2028)
Figure 74. Latin America Aminoglycoside Drug Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Aminoglycoside Drug Sales Share by Country (2017-2028)
Figure 76. Latin America Aminoglycoside Drug Revenue Share by Country (2017-2028)
Figure 77. Mexico Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 80. Colombia Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Aminoglycoside Drug Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Aminoglycoside Drug Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Aminoglycoside Drug Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Aminoglycoside Drug Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Aminoglycoside Drug Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Aminoglycoside Drug Revenue Share by Country (2017-2028)
Figure 87. Turkey Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Aminoglycoside Drug Revenue (2017-2028) & (US$ Million)
Figure 90. Aminoglycoside Drug Value Chain
Figure 91. Aminoglycoside Drug Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed